Fresenius closing book on its $4.2bn refi with IG-like pricing

Fresenius Medical Care, the US subsidiary of German global healthcare group Fresenius, is closing books on a $4.2bn refinancing loan this week, offering margins at a level more familiar to investment grade borrowers than those in the double-B pocket.